Archive: 01/11/2016

Mechanism of an effective MEK inhibitor identified

Understanding the effects of certain targeted therapies on antitumor immunity is necessary to design combined interventions for more effective cancer treatment. In the past, data have shown that trametinib, an FDA-approved ...

page 10 from 11